Gastroparesis is a heterogeneous disorder defined by delay in gastric emptying. Symptoms of gastroparesis are nonspecific, including nausea, vomiting, early satiety, bloating, and/or abdominal pain. Normal gastric motor function and…
Gastroparesis is characterized by delayed gastric emptying and symptoms thereof in the absence of gastric outlet obstruction. Most studies on the epidemiology of gastroparesis have been conducted in selected case…
Gastroparesis is a chronic symptomatic disorder of the stomach characterized by delayed emptying without evidence of mechanical obstruction. Symptoms of gastroparesis include nausea, vomiting, early satiety, postprandial fullness, and upper…
Henry P. Parkman, MD, Editor Related posts: Forthcoming Issues Other Forms of Gastroparesis Nutritional Considerations in the Patient with Gastroparesis Gastric Arrhythmias in Gastroparesis Idiopathic Gastroparesis Complementary and Alternative Medicine…
Forthcoming Issues June 2015 Barrett’s Esophagus Prasad G. Iyer and Navtej Buttar, Editors September 2015 Helicobacter pylori Therapies David Y. Graham and Akiko Shiotani, Editors December 2015 Hepatitis C Virus:…
Gary W. Falk, MD, MS, Consulting Editor Gastroparesis is undoubtedly one of the most frustrating disorders in gastroenterology for both patients and clinicians. The disease may be profoundly debilitating and,…
Chemoprevention in Barrett’s esophagus is currently applied only in research settings. Identifying pathways that can be targeted by safe, pharmaceutical or natural compounds is key to expanding the scope of…
Esophageal adenocarcinoma (EAC) develops from Barrett’s esophagus (BE), wherein normal squamous epithelia is replaced by specialized intestinal metaplasia in response to chronic gastroesophageal acid reflux. BE can progress to low-…
Patients with gastroesophageal reflux disease and Barrett’s esophagus can be a management challenge for the treating physician or surgeon. The goals of therapy include relief of reflux symptoms, induction of…
Barrett’s esophagus (BE) is present in up to 5.6% of the US population and is the precursor lesion for esophageal adenocarcinoma. Surveillance endoscopy is the primary management approach for BE….
